JP2007516219A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007516219A5 JP2007516219A5 JP2006529367A JP2006529367A JP2007516219A5 JP 2007516219 A5 JP2007516219 A5 JP 2007516219A5 JP 2006529367 A JP2006529367 A JP 2006529367A JP 2006529367 A JP2006529367 A JP 2006529367A JP 2007516219 A5 JP2007516219 A5 JP 2007516219A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- vaccine
- meningococcal
- human patient
- diphtheria
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229940124731 meningococcal vaccine Drugs 0.000 claims 18
- 229960005486 vaccine Drugs 0.000 claims 15
- 150000004676 glycans Chemical class 0.000 claims 12
- 229920001282 polysaccharide Polymers 0.000 claims 12
- 239000005017 polysaccharide Substances 0.000 claims 12
- 201000005702 Pertussis Diseases 0.000 claims 9
- 210000002966 serum Anatomy 0.000 claims 8
- 102000014914 Carrier Proteins Human genes 0.000 claims 7
- 108010078791 Carrier Proteins Proteins 0.000 claims 7
- 206010043376 Tetanus Diseases 0.000 claims 7
- 239000000427 antigen Substances 0.000 claims 7
- 102000036639 antigens Human genes 0.000 claims 7
- 108091007433 antigens Proteins 0.000 claims 7
- 206010013023 diphtheria Diseases 0.000 claims 7
- 102000016607 Diphtheria Toxin Human genes 0.000 claims 5
- 108010053187 Diphtheria Toxin Proteins 0.000 claims 5
- 229960003983 diphtheria toxoid Drugs 0.000 claims 4
- 238000002255 vaccination Methods 0.000 claims 4
- 239000002671 adjuvant Substances 0.000 claims 3
- -1 diphtheria toxoid Proteins 0.000 claims 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims 2
- 241000588724 Escherichia coli Species 0.000 claims 2
- 101710082714 Exotoxin A Proteins 0.000 claims 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 2
- 229940098773 bovine serum albumin Drugs 0.000 claims 2
- 108010045069 keyhole-limpet hemocyanin Proteins 0.000 claims 2
- 239000007788 liquid Substances 0.000 claims 2
- 239000012528 membrane Substances 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 229960000814 tetanus toxoid Drugs 0.000 claims 2
- 108010071023 Bacterial Outer Membrane Proteins Proteins 0.000 claims 1
- 231100000699 Bacterial toxin Toxicity 0.000 claims 1
- 101000812705 Gallus gallus Endoplasmin Proteins 0.000 claims 1
- 108010052285 Membrane Proteins Proteins 0.000 claims 1
- 102000018697 Membrane Proteins Human genes 0.000 claims 1
- 241000588650 Neisseria meningitidis Species 0.000 claims 1
- 108010058846 Ovalbumin Proteins 0.000 claims 1
- 206010035664 Pneumonia Diseases 0.000 claims 1
- 108010013381 Porins Proteins 0.000 claims 1
- 102000010912 Transferrin-Binding Proteins Human genes 0.000 claims 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 claims 1
- ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 claims 1
- 239000000688 bacterial toxin Substances 0.000 claims 1
- 238000004299 exfoliation Methods 0.000 claims 1
- 108010037896 heparin-binding hemagglutinin Proteins 0.000 claims 1
- 230000005847 immunogenicity Effects 0.000 claims 1
- 210000004072 lung Anatomy 0.000 claims 1
- 229940092253 ovalbumin Drugs 0.000 claims 1
- 102000007739 porin activity proteins Human genes 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 229910000162 sodium phosphate Inorganic materials 0.000 claims 1
- 239000001488 sodium phosphate Substances 0.000 claims 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 claims 1
- 229960001005 tuberculin Drugs 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US46858303P | 2003-05-07 | 2003-05-07 | |
| PCT/US2004/014337 WO2005004909A2 (en) | 2003-05-07 | 2004-05-07 | Method of enhanced immunogenicity to meningococcal vaccination |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010285610A Division JP2011068676A (ja) | 2003-05-07 | 2010-12-22 | 髄膜炎菌ワクチン接種に対する免疫原性の増強の方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007516219A JP2007516219A (ja) | 2007-06-21 |
| JP2007516219A5 true JP2007516219A5 (enExample) | 2007-08-02 |
Family
ID=34061894
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006529367A Pending JP2007516219A (ja) | 2003-05-07 | 2004-05-07 | 髄膜炎菌ワクチン接種に対する免疫原性の増強の方法 |
| JP2010285610A Pending JP2011068676A (ja) | 2003-05-07 | 2010-12-22 | 髄膜炎菌ワクチン接種に対する免疫原性の増強の方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010285610A Pending JP2011068676A (ja) | 2003-05-07 | 2010-12-22 | 髄膜炎菌ワクチン接種に対する免疫原性の増強の方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20050002948A1 (enExample) |
| EP (2) | EP1626737A2 (enExample) |
| JP (2) | JP2007516219A (enExample) |
| CN (1) | CN1819843A (enExample) |
| AU (2) | AU2004255526A1 (enExample) |
| BR (1) | BRPI0410423A (enExample) |
| CA (1) | CA2524853A1 (enExample) |
| WO (1) | WO2005004909A2 (enExample) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2228454T3 (es) * | 1999-02-26 | 2005-04-16 | Chiron S.R.L. | Mejora de la actividad bacteriana de antigenos de neisseria con oligonucleotidos que contienen motivos cg. |
| GB0406013D0 (en) * | 2004-03-17 | 2004-04-21 | Chiron Srl | Analysis of saccharide vaccines without interference |
| SI1740217T1 (sl) * | 2004-04-30 | 2011-10-28 | Novartis Ag | Konjugirano meningokokno cepljenje |
| GB0500787D0 (en) * | 2005-01-14 | 2005-02-23 | Chiron Srl | Integration of meningococcal conjugate vaccination |
| AU2005279821A1 (en) * | 2004-08-30 | 2006-03-09 | Sanofi Pasteur, Inc. | Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine |
| CA2621023C (en) | 2005-09-01 | 2019-07-02 | Novartis Vaccines And Diagnostics Gmbh & Co. Kg | Multiple vaccination including serogroup c meningococcus |
| JP2009521434A (ja) * | 2005-12-22 | 2009-06-04 | サノフィ パストゥール インコーポレイテッド | 髄膜炎菌由来の誘導体化多糖類−タンパク質の多価コンジュゲートおよびワクチン |
| US20080305127A1 (en) * | 2005-12-23 | 2008-12-11 | Glaxosmithkline Biologicals S.A. | Conjugate Vaccines |
| CA2644724C (en) * | 2006-03-17 | 2016-05-24 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Methods for preparing complex multivalent immunogenic conjugates |
| EP2007427A4 (en) | 2006-04-11 | 2012-04-04 | Yeda Res & Dev | IMPROVED VACCINES WITH MULTIMETER HSP60 PEPTIDE SUPPORTS |
| US7491517B2 (en) | 2006-07-19 | 2009-02-17 | Jeeri R Reddy | Method of producing meningococcal meningitis vaccine for Neisseria meningitidis serotypes A,C,Y, and W-135 |
| US8394391B2 (en) * | 2007-08-31 | 2013-03-12 | University Of Utah Research Foundation | Drug delivery vehicle that mimics viral properties |
| GB0822633D0 (en) | 2008-12-11 | 2009-01-21 | Novartis Ag | Formulation |
| US8003112B2 (en) * | 2009-04-16 | 2011-08-23 | Howard University | Meningococcal and pneumococcal conjugate vaccine and method of using same |
| WO2010139047A1 (en) * | 2009-06-01 | 2010-12-09 | Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Health | Reagents and methods for detecting influenza virus proteins |
| EP2550289A4 (en) * | 2010-03-12 | 2013-11-27 | Childrens Medical Center | NEW IMMUNOGENES AND METHODS FOR IDENTIFICATION AND SCREENING THEREOF |
| BR112012030337B1 (pt) * | 2010-05-28 | 2021-04-27 | Coley Pharmaceutical Group, Inc | Vacina compreendendo um ou mais oligonucleotídeo(s) de cpg isolado(s) ou um agonista de tlr e colesterol, e uso da mesma |
| CN102462839B (zh) * | 2010-11-12 | 2016-03-30 | 北京生物制品研究所 | 多糖结合疫苗及其制备方法 |
| AU2012253359B2 (en) | 2011-05-11 | 2017-06-08 | Children's Medical Center Corporation | Multiple antigen presenting immunogenic composition, and methods and uses thereof |
| US10428955B2 (en) * | 2012-06-25 | 2019-10-01 | Hamilton Sundstrand Corporation | Contamination resistant butterfly valve |
| CN103100081A (zh) * | 2012-12-26 | 2013-05-15 | 天津康希诺生物技术有限公司 | 一种多价联合疫苗 |
| CA2900008C (en) | 2013-02-07 | 2025-10-07 | Children's Medical Center Corporation | PROTEIN ANTIGENS THAT CONFER PROTECTION AGAINST COLONIZATION AND/OR PNEUMOCOCCAL DISEASE |
| CN107674118A (zh) * | 2016-08-02 | 2018-02-09 | 中国食品药品检定研究院 | 重组蛋白PspA1、PspA2和PspA3以及包含其的多糖结合疫苗 |
| CN106167519A (zh) * | 2016-08-10 | 2016-11-30 | 成都生物制品研究所有限责任公司 | 一种破伤风类毒素的制备方法 |
| EP3600400A4 (en) | 2017-03-28 | 2021-01-13 | The Children's Medical Center Corporation | MULTIPLE ANTIGEN PRESENTATION SYSTEM (MAPS) BASED STAPHYLOCOCCUS AUREUS VACCINE, IMMUNOGEN COMPOSITION AND THEIR USES |
| CN111065417B (zh) | 2017-06-23 | 2024-04-19 | 美商艾芬尼维克斯公司 | 免疫原性组合物 |
| KR102922338B1 (ko) | 2018-09-12 | 2026-02-05 | 더 칠드런스 메디칼 센터 코포레이션 | 폐렴구균 융합 단백질 백신 |
| TW202019470A (zh) | 2018-09-12 | 2020-06-01 | 美商艾芬尼維克斯公司 | 多價肺炎球菌疫苗 |
| CN109402035A (zh) * | 2018-11-06 | 2019-03-01 | 华中农业大学 | 一种肠外致病性大肠杆菌重组菌株及其应用 |
| WO2021059181A1 (en) | 2019-09-27 | 2021-04-01 | Pfizer Inc. | Neisseria meningitidis compositions and methods thereof |
| CN111024946A (zh) * | 2019-11-19 | 2020-04-17 | 江苏美克医学技术有限公司 | 阴道毛滴虫荧光免疫层析测定试剂盒及其制备方法 |
| WO2023039223A1 (en) | 2021-09-09 | 2023-03-16 | Affinivax, Inc. | Multivalent pneumococcal vaccines |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4356170A (en) | 1981-05-27 | 1982-10-26 | Canadian Patents & Development Ltd. | Immunogenic polysaccharide-protein conjugates |
| US4619828A (en) | 1982-07-06 | 1986-10-28 | Connaught Laboratories, Inc. | Polysaccharide exotoxoid conjugate vaccines |
| JPH0832638B2 (ja) | 1989-05-25 | 1996-03-29 | カイロン コーポレイション | サブミクロン油滴乳剤を含んで成るアジュバント製剤 |
| US5153312A (en) | 1990-09-28 | 1992-10-06 | American Cyanamid Company | Oligosaccharide conjugate vaccines |
| US5422427A (en) | 1991-09-17 | 1995-06-06 | The United States Of America As Represented By The United States Department Of Health And Human Services | Pneumococcal fimbrial protein A |
| US5445817A (en) | 1992-08-21 | 1995-08-29 | The United States Of America As Represented By The Department Of Health And Human Services | Pertussis toxin used as a carrier protein with non-charged saccharides in conjugate vaccines |
| US5965714A (en) | 1997-10-02 | 1999-10-12 | Connaught Laboratories, Inc. | Method for the covalent attachment of polysaccharides to protein molecules |
| US6146902A (en) | 1998-12-29 | 2000-11-14 | Aventis Pasteur, Inc. | Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions |
| GB0108364D0 (en) | 2001-04-03 | 2001-05-23 | Glaxosmithkline Biolog Sa | Vaccine composition |
| OA12302A (en) | 2000-06-29 | 2003-10-24 | Glaxosmithkline Biolog Sa | Multivalent vaccine composition. |
| EP2957300B1 (en) * | 2001-01-23 | 2021-07-14 | Sanofi Pasteur Inc. | Multivalent meningococcal polysaccharide-protein conjugate vaccine |
-
2004
- 2004-05-07 BR BRPI0410423-4A patent/BRPI0410423A/pt not_active IP Right Cessation
- 2004-05-07 EP EP04775955A patent/EP1626737A2/en not_active Withdrawn
- 2004-05-07 US US10/841,267 patent/US20050002948A1/en not_active Abandoned
- 2004-05-07 CA CA002524853A patent/CA2524853A1/en not_active Abandoned
- 2004-05-07 WO PCT/US2004/014337 patent/WO2005004909A2/en not_active Ceased
- 2004-05-07 JP JP2006529367A patent/JP2007516219A/ja active Pending
- 2004-05-07 AU AU2004255526A patent/AU2004255526A1/en not_active Abandoned
- 2004-05-07 EP EP10185661A patent/EP2301571A1/en not_active Withdrawn
- 2004-05-07 CN CNA2004800193051A patent/CN1819843A/zh active Pending
-
2010
- 2010-12-21 AU AU2010257354A patent/AU2010257354A1/en not_active Withdrawn
- 2010-12-22 JP JP2010285610A patent/JP2011068676A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007516219A5 (enExample) | ||
| JP2011042693A5 (enExample) | ||
| JP2006528936A5 (enExample) | ||
| Bröker et al. | Polysaccharide conjugate vaccine protein carriers as a “neglected valency”–potential and limitations | |
| JP2005526847A5 (enExample) | ||
| CA2366314A1 (en) | Protein d from haemophilus influenzae as a carrier protein in combination vaccines | |
| JP4870895B2 (ja) | ワクチン組成物 | |
| JP2005504718A5 (enExample) | ||
| RU2009134033A (ru) | Жидкие вакцины для множественных серогрупп менингококков | |
| RU2004136299A (ru) | Мукозальные вакцины с хитозановым адъювантом и/или антигенами менингококков | |
| JP2008526939A5 (enExample) | ||
| JP5074644B2 (ja) | 組合わせの髄膜炎菌ｂ／ｃワクチン | |
| JP2004501873A5 (enExample) | ||
| RU2004136295A (ru) | Комбинированные вакцины против бактериального менингита для введения через слизистую оболочку | |
| UA92579C2 (ru) | Поливалентная менингококовая полисахаридно-белковая конъюгированная вакцина | |
| JP2003520248A5 (enExample) | ||
| WO2007026249A3 (en) | Multiple vaccination including serogroup c meningococcus | |
| EP2172213A3 (en) | Injectable vaccines against multiple meningococcal serogroups | |
| US9956278B2 (en) | Multivalent meningococcal conjugates and methods for preparing conjugates | |
| US20100092519A1 (en) | Compositions comprising polysaccharide conjugates and their use as vaccines | |
| JP2007507487A5 (enExample) | ||
| RU2007130774A (ru) | Вакцинация менингококковыми конъюгатами | |
| RU2006142158A (ru) | Вакцинация менингококковыми конъюгатами | |
| JP2007516181A5 (enExample) | ||
| JP2007535527A5 (enExample) |